About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Our research group is accredited by the Agency for Management of University and Research Grants (AGAUR) in Catalonia, and focuses on two main areas of interest which are related to Solid Organ Transplantation and especially Kidney, and in clinical Nephrology. We tackle these areas from an innovative perspective, both basic-experimental and mechanistic, always with a translational goal. On the one hand, we investigate, develop, and use novel diagnostic and therapeutic technologies to decipher and target main molecular and immune mechanisms of transplant rejection as well as the immune susceptibility to opportunistic infections and malignancies. Also, a main task force of the group is devoted to better understand the main mechanisms involved in certain autoimmune glomerular diseases and idiopathic nephrotic syndrome as well as in diabetic kidney disease, having a specific interest in the role of the renin-angiotensin system. Our ultimate goal is to improve the management and care of patients suffering from kidney diseases as well as their quality of life, reducing associated morbidity and mortality.
PMID: 35497798 Journal: Kidney International Reports Year: 2022 Reference: Kidney Int Rep. 2021 Dec 16;7(4):797-809. doi: 10.1016/j.ekir.2021.11.037. eCollection 2022 Apr. Impact factor: 4.164 Publication type: Paper in international publication Authors: Bauer, Colin, Piani, Federica, Banks, Mindy, Ordonez, Flor A, de Lucas-Collantes, Carmen, Oshima, Kaori, Schmidt, Eric P, Zakharevich, Igor, Segarra, Alfons, Martinez, Cristina et al. DOI: 10.1016/j.ekir.2021.11.037
PMID: 35475363 Journal: Multiple Sclerosis Journal Year: 2022 Reference: Mult Scler. 2022 Jun;28(7):1138-1145. doi: 10.1177/13524585221089540. Epub 2022 Apr 27. Impact factor: 6.312 Publication type: Paper in international publication Authors: Arrambide, Georgina, Otero-Romero, Susana, Pappolla, Agustin, Tagliani, Paula, Lopez-Maza, Samuel, Cardenas-Robledo, Simon, Esperalba, Juliana, Fernandez-Naval, Candela, Martinez-Gallo, Monica, Castillo, Mireia et al. DOI: 10.1177/13524585221089540
PMID: 33547795 Journal: NEPHROLOGY DIALYSIS TRANSPLANTATION Year: 2022 Reference: Nephrol Dial Transplant. 2022 Apr 25;37(5):887-894. doi: 10.1093/ndt/gfab034. Impact factor: 5.992 Publication type: Paper in international publication Authors: Garcia-Carro, Clara, Bolufer, Monica, Bury, Roxana, Cataneda, Zaira, Munoz, Eva, Felip, Enriqueta, Lorente, David, Josep Carreras, Maria, Gabaldon, Alejandra, Seron, Daniel et al. DOI: 10.1093/ndt/gfab034
PMID: 35410878 Journal: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY Year: 2022 Reference: J Am Soc Nephrol. 2022 Jun;33(6):1223-1224. doi: 10.1681/ASN.2022020164. Epub 2022 Apr 11. Impact factor: 10.121 Publication type: Letter or abstract Authors: Specks, Ulrich, Casal Moura, Marta, Soler, Maria Jose, Sethi, Sanjeev, Fervenza, Fernando C et al. DOI: 10.1681/ASN.2022020164
PMID: 33064917 Journal: Transplant Infectious Disease Year: 2021 Reference: Transpl Infect Dis. 2021 Apr;23(2):e13494. doi: 10.1111/tid.13494. Epub 2020 Oct 27. Impact factor: 2.228 Publication type: Paper in international publication Authors: Anaya, Fernando, Lopez-Hoyos, Marcos, Rodrigo, Emilio, Arias, Manuel, Perello, Manel, Seron, Daniel, Karanovic, Boris, Ezzahouri, Ikram, Mezzano, Sergio, Jaramillo, Maria et al. DOI: 10.1111/tid.13494
PMID: 33888348 Journal: NEFROLOGIA Year: 2021 Reference: Nefrologia (Engl Ed). 2021 Apr 19. pii: S0211-6995(21)00058-8. doi: 10.1016/j.nefro.2021.03.002. Impact factor: 2.033 Publication type: Letter or abstract Authors: LeonRoman, Juan, Vergara, Ander, Agraz, Irene, Garcia-Carro, Clara, Bermejo, Sheila, Gabaldon, Alejandra, Soler, Maria Jose et al. DOI: 10.1016/j.nefro.2021.03.002
PMID: 33887895 Journal: Minerva urology and nephrology Year: 2021 Reference: Minerva Urol Nephrol. 2021 Apr 22. pii: S2724-6051.21.04345-7. doi: 10.23736/S2724-6051.21.04345-7. Impact factor: 0 Publication type: Paper in international publication Authors: Miret, Enric, Moreso, Francesc, Toapanta, Nestor, Lorente, David, Triquell, Marina, Pont, Teresa, Perez-Hoyos, Santiago, Seron, Daniel, Morote, Juan, Trilla, Enrique et al. DOI: 10.23736/S2724-6051.21.04345-7
PMID: 33811970 Journal: MOLECULAR AND CELLULAR ENDOCRINOLOGY Year: 2021 Reference: Mol Cell Endocrinol. 2021 Jun 1;529:111263. doi: 10.1016/j.mce.2021.111263. Epub 2021 Mar 31. Impact factor: 4.102 Publication type: Paper in international publication Authors: Soler, Maria Jose, Seron, Daniel, Garcia-Carro, Clara, Vergara, Ander, Jacobs-Cacha, Conxita, Molina-Van den Bosch, Mireia, Dominguez-Baez, Pamela, Benito, Begona et al. DOI: 10.1016/j.mce.2021.111263
The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.
Hypertension, a key risk factor for heart disease that contributes significantly to cardiovascular mortality and morbidity and damage to vital organs, was the focus of this multi-centre study.
The new findings were presented at the American Society of Nephrology's Kidney Week 2024 meeting in San Diego and simultaneously published in the prestigious journal Nature Medicine.
